Idience Co.
Latest round
- Series B
Last raised
- Jul 2022
Total raised
- $40M
Investors
- 4
About Idience Co.
, Ltd. is engaged in developing innovative biopharmaceutical solutions, primarily focusing on oncology through its leading product, Venadaparib (ID11916), a PARP inhibitor designed to enhance cancer treatment., Ltd. is situated in Seoul, South Korea, specializing in biopharmaceuticals. The company was established by Aleksei Igorevich, who has experience in leading other ventures., Ltd.471 million., Ltd. specializes in developing innovative biopharmaceutical solutions focused on oncology, with a primary emphasis on its key product, Venadaparib (ID11916), a PARP inhibitor. This medication is intended to improve cancer treatment outcomes by targeting DNA repair mechanisms in tumor cells.6 million. The company generates revenue primarily through direct sales of Venadaparib, engaging in B2B relationships with healthcare providers and institutions, where transactions typically occur through agreements with hospitals and oncology clinics., Ltd. The company aims to expand its reach into new geographic markets, particularly in the United States and Europe, enhancing patient access to its innovative therapies.
Who invested in Idience Co.
4 investors across 2 rounds
See all investors in Idience Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Idience Co.
Who invested in Idience Co.?
Idience Co. has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Idience Co. raised?
Idience Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Idience Co. last raise money?
Idience Co.'s most recent round on record is a Series B, in Jul 2022.
What does Idience Co. do?
Idience Co. is a healthcare specialists company.
Where is Idience Co. headquartered?
Idience Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like Idience Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare specialists companies at Idience Co.'s stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like Idience Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.